DENVER–(BUSINESS WIRE)–Mar 12, 2026–
Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II clinical trial (RCT), offering an early signal that could reshape how advanced pancreatic cancer is treated. Conducted in partnership with USC Norris Comprehensive Cancer Center, Mayo Clinic, HonorHealth Research Institute, and others, the study was peer-reviewed and published in Cancer, revealing that Virta’s medically supervised, individualized nutrition therapy—long proven effective in reversing metabolic diseases like type 2 diabetes and obesity—also shows promise in extending survival in patients with metastatic pancreatic cancer when used alongside chemotherapy.
kAm%9:D AC6DD C6=62D6 762EFC6D >F=E:>65:2] ‘:6H E96 7F== C6=62D6 96C6i k2 9C67lQ9EEADi^^HHH]3FD:?6DDH:C6]4@>^?6HD^9@>6^a_ae_b`aafhddb^6?^Q C6=lQ?@7@==@HQm9EEADi^^HHH]3FD:?6DDH:C6]4@>^?6HD^9@>6^a_ae_b`aafhddb^6?^k^2mk^Am
kAm%96 EC:2= 6?C@==65 A2E:6?ED H:E9 DE286 x’ >6E2DE2E:4 A2?4C62E:4 42?46C[ H96C6 E96 >65:2? =:76 6IA64E2?4J 😀 e E@ `a >@?E9D] p== A2CE:4:A2?ED C646:G65 2 EC:A=6E 496>@E96C2AJ C68:>6?—86>4:E23:?6[ ?23\A24=:E2I6=[ 2?5 4:DA=2E:?—2?5 H6C6 C2?5@>:K65 E@ 6:E96C ‘:CE2’D ?FEC:E:@? E96C2AJ @C 2 DE2?52C5 5:6E] !2E:6?ED 😕 E96 ‘:CE2 2C> =:G65 bcT =@?86C E92? E9@D6 😕 E96 4@?EC@= W2G6C286 `b]f GD] `_]a >@?E9DX[ 2?5 AC@8C6DD:@?\7C66 DFCG:G2= :>AC@G65 3J bfT W2G6C286 g]d GD] e]a >@?E9DX] %96 EC:2= >6E :ED @3;64E:G6[ 56>@?DEC2E:?8 762D:3:=:EJ 2?5 2 EC6?5 E@H2C5 :>AC@G6>6?E 😕 AC@8C6DD:@?\7C66 DFCG:G2=—2== H:E9@FE 25565 E@I:4:EJ @C 564=:?6 😕 BF2=:EJ @7 =:76—@? ‘:CE2]k^Am
kAm“!2?4C62E:4 42?46C 😀 2>@?8 E96 5625=:6DE 42?46CD[ 2?5 :>AC@G:?8 @FE4@>6D 3J 2?J >2C8:? 😀 C2C6[” D2:5 p52> (@=736C8[ |s[ |!w[ 2?5 r9:67 |65:42= ~77:46C @7 ‘:CE2] “$66:?8 2 ?FEC:E:@?2= :?E6CG6?E:@?—56=:G6C65 C6>@E6=J 2?5 D276=J—>2<6 E9:D =6G6= @7 :>A24E 😀 6IEC2@C5:?2CJ]”k^Am
kAmx? 2 7:6=5 H96C6 564256D @7 5CF8 56G6=@A>6?E 92G6 J:6=565 @?=J :?4C6>6?E2= 82:?D[ E9:D EC:2= >2C:D:?8 EC6?5 E@H2C5 =:76 6IE6?D:@? H:E9@FE :?4C62D:?8 D:56 67764ED—D@>6E9:?8 76H[ :7 2?J[ 4FCC6?E =:76DEJ=6 E96C2A:6D 42? 4=2:>]k^Am
kAm“%96 >6492?:D> @7 24E:@? 😀 ?@E 7F==J F?56CDE@@5[ 3FE E9:D ?FEC:E:@? 2AAC@249 92D D9@H? 😕 AC64=:?:42= H@C< E@ :>AC@G6 E96 67764E @7 2?E:\42?46C E96C2AJ[ 2?5 E92E H2D D9@H? 😕 E9:D 4=:?:42= EC:2=[” D2:5 tC
kAmsC] q@C2K2?4: D2:5 C6D62C496CD 9@A6 E@ 4@?7:C> E96:C 7:?5:?8D E9C@F89 2 =2C86C DEF5J]k^Am
kAm(9:=6 AC6G:@FD =23 DEF5:6D 92G6 DF886DE65 E9:D 4@??64E:@?[ 4=:?:42= 6G2=F2E:@? @7 ?FEC:E:@?2= :?E6CG6?E:@?D E2C86E:?8 42?46C >6E23@=:D> C6>2:?D =:>:E65[ A2CE:4F=2C=J 😕 288C6DD:G6 42?46CD] %96 AC@8C2> FD65 😕 E96 EC:2= H2D 56G6=@A65 2?5 25>:?:DE6C65 3J ‘:CE2 2?5 :?4=F56D :?5:G:5F2=:K65 ?FEC:E:@?[ 3:@>2C<6C EC24<:?8[ px E@@=D[ `i` 4@249:?8[ 2?5 4@?E:?F@FD >65:42= DFA6CG:D:@? 3J ‘:CE2 AC@G:56CD]k^Am
kAm“%96D6 C6DF=ED 7FCE96C G2=:52E6 E92E ‘:CE2’D 2AAC@249 :D?’E 23@FE H6:89E =@DD @C 42=@C:6 4@F?E:?8—:E’D 23@FE 255C6DD:?8 E96 C@@E 42FD6 @7 >6E23@=:4 5JD7F?4E:@? E92E 5C:G6D 5:D62D6[” D2:5 (@=736C8] “%92E’D H9J @FC >6E9@5 H@C:D:?8 DJ?6C8:DE:4 67764ED 2=@?8D:56 EC25:E:@?2= 42?46C E96C2A:6D]”k^Am
kAm&?=:<6 EC25:E:@?2= H6:89E =@DD 2AAD @C 42=@C:6\4@F?E:?8 A=2E7@C>D[ ‘:CE2 56=:G6CD >65:42==J DFA6CG:D65 ?FEC:E:@? E96C2AJ C@@E65 😕 D4:6?46 2?5 56D:8?65 E@ C6G6CD6—?@E ;FDE >2?286—>6E23@=:4 5:D62D6D =:<6 @36D:EJ 2?5 EJA6 a 5:236E6D]k^Am
kAm%9:D =2E6DE DEF5J C6AC6D6?ED ‘:CE2’D 2>3:E:@FD A=2? E@ 6IA2?5 :?E@ ?6H 4=:?:42= :?5:42E:@?D C6=2E65 E@ >6E23@=:4 5:D62D6] “%9:D 😀 ?@E 2 =F4: x?<:?6?] “p7E6C >@C6 E92? 2 564256 C6G6CD:?8 EJA6 a 5:236E6D[ @36D:EJ[ 2?5 E96:C C6=2E65 4@\>@C3:5:E:6D[ H6 @H ?FEC:E:@? 😀 E96 <6J E@ 255C6DD:?8 >6E23@=:4 5:D62D6 2?5 E96 >2?J 4@?5:E:@?D :E 5C:G6D] %9:D DEF5J @776CD @FC 7:CDE :?5:42E:@? E92E E96 ‘:CE2 A=2E7@C> >2J :>AC@G6 @FE4@>6D 😕 6G6? E96 5625=:6DE 4@?5:E:@?D[ 2?5 H:== 8F:56 FD 2D H6 7FCE96C 3F:=5 @FC A:A6=:?6 @7 AC@8C2>D 2?5 C6D62C49] u@C FD[ :E’D DE:== s2J ~?6]”k^Am
kAmk6>mp3@FE ‘:CE2 w62=E9k^6>mk^Am
kAm’:CE2 w62=E9 😀 E96 =6256C 😕 C6G6CD:?8 >6E23@=:4 5:D62D6] %9C@F89 E96:C px\A@H6C65 :?5:G:5F2=:K65 ?FEC:E:@? E96C2AJ[ ‘:CE2 4@>3:?6D E96 36DE @7 9F>2? 42C6 H:E9 E96 DA665 2?5 AC64:D:@? @7 E649?@=@8J E@ 6>A@H6C >6>36CD E@ 3F:=5 =@?86C[ 962=E9:6C =:G6D[ H9:=6 C65F4:?8 @C 6=:>:?2E:?8 E96 ?665 7@C >65:42E:@?D] ‘:CE2 A2CE?6CD H:E9 E96 ?2E:@?’D =2C86DE 6>A=@J6CD[ A2J6CD[ 2?5 A92C>24J 36?67:E >2?286CD E@ :>AC@G6 E96 962=E9 @7 E96:C >6>36CD H9:=6 C65F4:?8 4@DED] w625BF2CE6C65 😕 s6?G6C[ r@=@C25@[ ‘:CE2 😀 @? 2 3@=5 >:DD:@? E@ C6G6CD6 >6E23@=:4 5:D62D6 😕 @?6 3:==:@? A6@A=6] u@C >@C6 :?7@C>2E:@?[ G:D:E k2 9C67lQ9EEADi^^4ED]3FD:?6DDH:C6]4@>^4E^r%n:5lD>2CE=:?AjFC=l9EEATbpTauTauHHH]G:CE2962=E9]4@>U2>Aj6D966EldcccdageU2>Aj?6HD:E6>:5la_ae_b`aafhddbU2>Aj=2?l6?\&$U2>Aj2?49@ClHHH]G:CE2962=E9]4@>U2>Aj:?56Il`U2>Aj>5dld5b66e2ae7c3f7`35b224c_5e3e_fe_4Q C6=lQ?@7@==@HQ D92A6lQC64EQmHHH]G:CE2962=E9]4@>k^2m]k^Am
kE23=6 46==DA24:?8lQ_QmkECmkE5mk9C ^mk^E5mk^ECmk^E23=6m
kAmk6>m}~%t$k^6>mk^Am
kAmy2>6D@? v$[ #@6 sy[ q@C2K2?4: t[ w2??2 s{[ #@36CED rv![ !6=DE6C |$[ uC2?< #r[ p=:DE2C p%[ |:==6C p|[ (:65>6:6C\}FE@C yt[ p=82K6 $s[ +@==6C p#[ w2==36C8 $y[ (6CE96:> qr[ {66 z[ rC:563C:?8 s[ #23:?@H:EK ys[ v2E6=J $[ z6AA=6C y[ $92C>2 $[ ‘@? w@77 ss[ #2D4@ s(] k6>mp C2?5@>:K65 A92D6 xx EC:2= @7 86>4:E23:?6[ ?23\A24=:E2I6=[ 4:DA=2E:? H:E9 @C H:E9@FE 2 >65:42==J DFA6CG:D65 <6E@86?:4 5:6E 7@C A2E:6?ED H:E9 >6E2DE2E:4 A2?4C62E:4 42?46Ck^6>m] r2?46C] a_aej6f_bcb] 5@:i`_]`__a^4?4C]f_bcbk^Am
kAmk6>mp #2?5@>:K65 !92D6 xx %C:2= @7 v6>4:E23:?6[ }23\!24=:E2I6=[ r:DA=2E:? H:E9 @C H:E9@FE 2 |65:42==J $FA6CG:D65 z6E@86?:4 s:6E 7@C !2E:6?ED H:E9 |6E2DE2E:4 !2?4C62E:4 r2?46Ck^6>m 42? 36 2446DD65 2Ei k2 9C67lQ9EEADi^^4ED]3FD:?6DDH:C6]4@>^4E^r%n:5lD>2CE=:?AjFC=l9EEADTbpTauTau24D;@FC?2=D]@?=:?6=:3C2CJ]H:=6J]4@>Tau5@:Tau23DTau`_]`__aTau4?4C]f_bcbU2>Aj6D966EldcccdageU2>Aj?6HD:E6>:5la_ae_b`aafhddbU2>Aj=2?l6?\&$U2>Aj2?49@Cl9EEADTbpTauTau24D;@FC?2=D]@?=:?6=:3C2CJ]H:=6J]4@>Tau5@:Tau23DTau`_]`__aTau4?4C]f_bcbU2>Aj:?56IlaU2>Aj>5dlfeg6_6defce3`f_`6c6__5aa6h_b2_6hQ C6=lQ?@7@==@HQ D92A6lQC64EQm9EEADi^^24D;@FC?2=D]@?=:?6=:3C2CJ]H:=6J]4@>^5@:^23D^`_]`__a^4?4C]f_bcbk^2mk^Am
kAm’:6H D@FC46 G6CD:@? @? k2 9C67lQ9EEAi^^3FD:?6DDH:C6]4@>Qm3FD:?6DDH:C6]4@>k^2mik2 9C67lQ9EEADi^^HHH]3FD:?6DDH:C6]4@>^?6HD^9@>6^a_ae_b`aafhddb^6?^Q C6=lQ?@7@==@HQm9EEADi^^HHH]3FD:?6DDH:C6]4@>^?6HD^9@>6^a_ae_b`aafhddb^6?^k^2mk^Am
kAmr~}%pr%i yF5J wF2?8k^Am
kAmk2 9C67lQ>2:=E@iAC6DDoG:CE2962=E9]4@>QmAC6DDoG:CE2962=E9]4@>k^2mk^Am
kAmzt*(~#si r~{~#ps~ &}x%ts $%p%t$ }~#%w p|t#xrpk^Am
kAmx}s&$%#* zt*(~#si %trw}~{~v* sxpqt%t$ ux%}t$$ U2>Aj }&%#x%x~} r{x}xrp{ %#xp{$ $~u%(p#t vt}t#p{ wtp{%w wtp{%w sp%p |p}pvt|t}% ~}r~{~v* p#%xuxrxp{ x}%t{{xvt}rtk^Am
kAm$~rti ‘:CE2 w62=E9k^Am
kAmr@AJC:89E qFD:?6DD (:C6 a_ae]k^Am
kAm!&qi _b^`a^a_ae _ai_c !|^sx$ri _b^`a^a_ae _ai_c !|k^Am
kAmk2 9C67lQ9EEAi^^HHH]3FD:?6DDH:C6]4@>^?6HD^9@>6^a_ae_b`aafhddb^6?Qm9EEAi^^HHH]3FD:?6DDH:C6]4@>^?6HD^9@>6^a_ae_b`aafhddb^6?k^2mk^Am
Copyright Business Wire 2026.
